Microplate-based automatic blood grouping analyzer Metis of Aikang MedTech Co., Ltd. (henceforth referred to as Aikang) received approval for marketing in 2015; and its MGT-based automatic blood grouping analyzer Aigel received approval for marketing in 2016.

Themed "Global IVD Innovation & Cross-Regional Integration," this groundbreaking event brings together distinguished experts from around the world to explore the future of diagnostics.

Danaher subsidiary Leica Biosystems said Monday that it secured US Food and Drug Administration 510(k) clearance for its Bond MMR Antibody Panel to help identify potential Lynch syndrome in colorectal cancer patients.

Sysmex Europe and Cerca Biotech said Monday that they have inked a deal for Sysmex to distribute Cerca's molecular breast cancer assay in 13 European markets.

Recently, WillingMed Technology(Beijing) Co., Ltd. announced the completion of a CNY hundreds of millions Series B financing round.

Stilla Technologies and Atila BioSystems said on Thursday that they will codevelop digital PCR kits for cancer liquid biopsy applications.

C2N Diagnostics announced the publication of a study further confirming the sensitivity of its PrecivityAD blood test for diagnosing Alzheimer’s disease.

On March 29, 2023, Hybribio and MGI Tech signed an agreement to reach strategic cooperation in the direction of high-throughput sequencing platform to expand international market.

The US Food and Drug Administration this week released its guidance document for developers of medical devices for COVID-19, including diagnostic tests, on how to transition from Emergency Use Authorization to full marketing and regulatory authorization.

Roche Diagnostics and ABL Diagnostics announced on Thursday that they have entered an exclusive agreement for Roche to distribute ABL's assays to South African laboratories.

To further promote the construction of a Healthy China planning a new "construction plan", the State Council issued the "Healthy China Initiative (2019-2030)", the program focuses on the current major health problems and factors affecting the two core disease prevention and health promotion.

BGI Genomics is pleased to announce the launch of COLOTECTTM 1.0 in Slovakia, in collaboration with its partner, Zentya.